• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Research Briefing on 3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile (CAS: 90006-21-6) in Chemical Biology and Pharmaceutical Applications

3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile (CAS: 90006-21-6) is a brominated pyrazole derivative that has recently garnered attention in chemical biology and pharmaceutical research due to its versatile reactivity and potential as a building block for bioactive molecules. This compound, characterized by its nitrile functional group and bromo-substituted pyrazole ring, serves as a key intermediate in the synthesis of heterocyclic compounds with applications in drug discovery and agrochemical development. Recent studies have explored its utility in medicinal chemistry, particularly in the design of kinase inhibitors and anti-inflammatory agents.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of 90006-21-6 as a precursor for novel JAK2 kinase inhibitors. The bromo-substitution at the 4-position of the pyrazole ring was found to facilitate palladium-catalyzed cross-coupling reactions, enabling efficient derivatization. The nitrile group further enhanced binding affinity through dipole interactions with kinase active sites. This work highlights the compound's significance in targeting cytokine signaling pathways implicated in autoimmune diseases.

Another recent application emerged in agrochemical research, where 3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile was utilized as a core structure for developing next-generation fungicides. A 2024 Pest Management Science publication demonstrated its effectiveness as a scaffold for compounds inhibiting fungal ergosterol biosynthesis. The bromine atom's presence was crucial for maintaining potency against resistant strains of Fusarium species, while the nitrile group contributed to improved systemic mobility in plant tissues.

Synthetic methodology developments have also advanced significantly. A 2023 Organic Letters report detailed a novel continuous-flow protocol for the large-scale production of 90006-21-6, achieving 92% yield with reduced hazardous waste generation compared to batch processes. This technological advancement addresses previous scalability challenges and supports the compound's growing industrial applications.

From a safety perspective, recent toxicological assessments (2024, Regulatory Toxicology and Pharmacology) have established preliminary exposure limits for 3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile in occupational settings. While showing moderate acute toxicity (LD50 = 320 mg/kg in rats), the compound demonstrated no significant genotoxicity in Ames tests, supporting its continued use in research applications with proper handling precautions.

Looking forward, the unique structural features of 90006-21-6 position it as a valuable tool for chemical biology probe development. Current research directions include its incorporation into PROTAC (PROteolysis TArgeting Chimera) molecules and as a versatile intermediate for diversity-oriented synthesis. The compound's dual functionality (bromo for coupling and nitrile for further transformations) continues to make it a focus of innovation in pharmaceutical chemistry.

• 175137-59-4((4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile)
• 1171717-09-1(4-Bromo-3,5-dimethyl-1-(3-methylbutyl)-1H-pyrazole)
• 1171526-62-7(4-Bromo-1-isobutyl-3,5-dimethyl-1H-pyrazole)
• 925607-98-3(3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propan-1-ol)
• 51108-52-2(4-bromo-1-isopropyl-3,5-dimethyl-1H-pyrazole)
• 1004017-87-1(1-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-one)
• 51108-51-1(4-Bromo-1-ethyl-3,5-dimethyl-1H-pyrazole)
• 1171667-09-6(4-Bromo-1-ethyl-5-methyl-1H-pyrazole)
• 562815-07-0(2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethanamine)
• 652982-93-9(2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-ol)